MRK
Merck & Company Inc
NYSE: MRK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$109.18
-1.60% today
Updated 2026-04-29
Market cap
$274.03B
P/E ratio
15.24
P/S ratio
4.22x
EPS (TTM)
$7.28
Dividend yield
2.94%
52W range
$71 – $124
Volume
9.8M
Merck & Company Inc (MRK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
28.10%
Operating margin
32.80%
ROE
36.90%
ROA
12.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $22.64B | $4.43B | 73.49% | 16.29% | 19.59% |
| 2007 | $24.20B | $3.28B | 74.62% | 23.22% | 13.54% |
| 2008 | $23.85B | $7.81B | 76.59% | 25.51% | 32.74% |
| 2009 | $27.43B | $12.90B | 67.12% | 14.66% | 47.03% |
| 2010 | $45.99B | $861.00M | 60.00% | 7.30% | 1.87% |
| 2011 | $48.05B | $6.27B | 64.89% | 18.68% | 13.05% |
| 2012 | $47.27B | $6.17B | 65.21% | 20.90% | 13.05% |
| 2013 | $44.03B | $4.40B | 61.50% | 17.41% | 10.00% |
| 2014 | $42.24B | $11.92B | 60.30% | 15.82% | 28.22% |
| 2015 | $39.50B | $4.44B | 62.19% | 19.11% | 11.25% |
| 2016 | $39.81B | $3.92B | 64.75% | 13.81% | 9.85% |
| 2017 | $40.12B | $2.39B | 67.82% | 16.94% | 5.97% |
| 2018 | $42.29B | $6.22B | 68.06% | 21.12% | 14.71% |
| 2019 | $39.12B | $9.84B | 69.29% | 20.26% | 25.16% |
| 2020 | $41.52B | $7.07B | 67.20% | 13.36% | 17.02% |
| 2021 | $48.70B | $13.05B | 72.02% | 27.10% | 26.79% |
| 2022 | $59.28B | $14.52B | 70.63% | 30.84% | 24.49% |
| 2023 | $60.12B | $365.00M | 73.17% | 4.91% | 0.61% |
| 2024 | $64.17B | $17.12B | 76.32% | 31.51% | 26.68% |
| 2025 | $65.01B | $18.25B | 81.50% | 41.19% | 28.08% |